• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗生素暴露中断频率与医疗保健相关感染风险之间的关联

The Association Between the Frequency of Interruptions in Antibiotic Exposure and the Risk of Health Care-Associated Infection.

作者信息

Song Jiyoun, Cohen Bevin, Liu Jianfang, Larson Elaine, Zachariah Philip

机构信息

Columbia University School of Nursing, New York, New York.

Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.

出版信息

Curr Ther Res Clin Exp. 2020 Aug 5;93:100600. doi: 10.1016/j.curtheres.2020.100600. eCollection 2020.

DOI:10.1016/j.curtheres.2020.100600
PMID:32904045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7451585/
Abstract

BACKGROUND

Although antibiotic use is an established risk factor for health care-associated infection, estimates of the association between infection and antibiotic use vary, depending upon how antibiotic exposure is measured.

OBJECTIVES

The purpose of this study was to explore the association between the frequency of interruptions in antibiotic exposure and the risk of health care-associated infection.

METHODS

A retrospective chart review cohort study was conducted of all inpatients between 2011and 2016 from a single academic health center who received at least 1 dose of a systemic antibacterial for a cumulative duration of >3 days and ≤30 days. The measures of antibiotic exposure examined were durationcumulative total calendar days of antibiotics therapy-and continuity-the frequency of interruptions in antibiotic exposure that was defined as the number of antibiotic treatment courses.

RESULTS

A total of 52,445/227,967 (23%) patients received antibacterial therapy for >3 days and ≤30 days during their hospitalization. Of these, 1161 out of 52,445 (2.21%) were patients with health care-associated infection. An adjusted multivariable logistic regression analysis revealed that the risk of increased with longer cumulative days (odds ratio = 2.7; comparison of >12 days to ≤5 days) and fewer interruptions of antibiotic treatment (odds ratio = 0.78; comparison of >3 discrete antibiotic treatment courses to 1 course or continuous antibiotic treatment course; all values < 0.05).

CONCLUSIONS

For patients who received the same number of cumulative days of therapy, the patients who had more frequently interrupted courses of antibiotic therapy were less likely to experience health care-associated infection. (. 2020; 81:XXX-XXX).

摘要

背景

尽管抗生素使用是医疗保健相关感染的既定风险因素,但感染与抗生素使用之间关联的估计值各不相同,这取决于抗生素暴露的测量方式。

目的

本研究的目的是探讨抗生素暴露中断频率与医疗保健相关感染风险之间的关联。

方法

对2011年至2016年期间来自单一学术医疗中心的所有住院患者进行回顾性病历队列研究,这些患者接受了至少1剂全身性抗菌药物治疗,累积疗程超过3天且≤30天。所检查的抗生素暴露指标包括疗程(抗生素治疗的累计总日历天数)和连续性(抗生素暴露中断的频率,定义为抗生素治疗疗程数)。

结果

共有52445/227967(23%)的患者在住院期间接受了超过3天且≤30天的抗菌治疗。其中,52445名患者中有1161名(2.21%)发生了医疗保健相关感染。多变量校正逻辑回归分析显示,累积天数越长(比值比=2.7;比较>12天与≤5天)和抗生素治疗中断次数越少(比值比=0.78;比较>3个离散抗生素治疗疗程与1个疗程或连续抗生素治疗疗程;所有P值<0.05),感染风险越高。

结论

对于接受相同累积治疗天数的患者,抗生素治疗疗程中断更频繁的患者发生医疗保健相关感染的可能性较小。(. 2020;81:XXX - XXX)

相似文献

1
The Association Between the Frequency of Interruptions in Antibiotic Exposure and the Risk of Health Care-Associated Infection.抗生素暴露中断频率与医疗保健相关感染风险之间的关联
Curr Ther Res Clin Exp. 2020 Aug 5;93:100600. doi: 10.1016/j.curtheres.2020.100600. eCollection 2020.
2
Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection.医院病房抗生素处方与艰难梭菌感染的风险。
JAMA Intern Med. 2015 Apr;175(4):626-33. doi: 10.1001/jamainternmed.2014.8273.
3
The Urine-culturing Cascade: Variation in Nursing Home Urine Culturing and Association With Antibiotic Use and Clostridiodes difficile Infection.尿液培养级联:养老院尿液培养的变化与抗生素使用和艰难梭菌感染的关系。
Clin Infect Dis. 2020 Apr 10;70(8):1620-1627. doi: 10.1093/cid/ciz482.
4
Antibiotic Prescribing Choices and Their Comparative C. Difficile Infection Risks: A Longitudinal Case-Cohort Study.抗生素处方选择及其比较的艰难梭菌感染风险:一项纵向病例队列研究。
Clin Infect Dis. 2021 Mar 1;72(5):836-844. doi: 10.1093/cid/ciaa124.
5
Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection.随着时间的推移累积的抗生素暴露与艰难梭菌感染的风险。
Clin Infect Dis. 2011 Jul 1;53(1):42-8. doi: 10.1093/cid/cir301.
6
Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.国家 4C 抗生素管理干预对苏格兰某地区艰难梭菌感染的临床和分子流行病学的影响:非线性时间序列分析。
Lancet Infect Dis. 2017 Feb;17(2):194-206. doi: 10.1016/S1473-3099(16)30397-8. Epub 2016 Nov 4.
7
Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.抗生素暴露与医院获得性艰难梭菌感染风险
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.02169-19.
8
Oral vancomycin prophylaxis during systemic antibiotic exposure to prevent Clostridiodes difficile infection relapses.在全身应用抗生素期间口服万古霉素预防,以防止艰难梭菌感染复发。
Infect Control Hosp Epidemiol. 2019 Jun;40(6):662-667. doi: 10.1017/ice.2019.88. Epub 2019 Apr 29.
9
Importation, Antibiotics, and Clostridium difficile Infection in Veteran Long-Term Care: A Multilevel Case-Control Study.退伍军人长期护理中的进口、抗生素与艰难梭菌感染:一项多层次病例对照研究。
Ann Intern Med. 2016 Jun 21;164(12):787-94. doi: 10.7326/M15-1754. Epub 2016 Apr 19.
10
Clostridioides difficile-Associated Diarrhea: Infection Prevention Unknowns and Evolving Risk Reduction Strategies.艰难梭菌相关性腹泻:感染预防的未知因素与不断演变的风险降低策略
Curr Infect Dis Rep. 2019 Jan 23;21(1):1. doi: 10.1007/s11908-019-0659-8.

引用本文的文献

1
A Systematic Literature Review on Risk Factors for and Timing of Clostridioides difficile Infection in the United States.美国艰难梭菌感染的危险因素及发生时间的系统文献综述
Infect Dis Ther. 2024 Feb;13(2):273-298. doi: 10.1007/s40121-024-00919-0. Epub 2024 Feb 13.

本文引用的文献

1
Temporal change of risk factors in hospital-acquired infection using time-trend analysis.采用时间趋势分析研究医院获得性感染的危险因素的时间变化。
Infect Control Hosp Epidemiol. 2020 Sep;41(9):1048-1057. doi: 10.1017/ice.2020.206. Epub 2020 May 29.
2
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).临床实践指南:成人和儿童艰难梭菌感染:美国传染病学会(IDSA)和美国医疗保健流行病学学会(SHEA) 2017 年更新。
Clin Infect Dis. 2018 Mar 19;66(7):e1-e48. doi: 10.1093/cid/cix1085.
3
Risk factors for infections - an overview of the evidence base and challenges in data synthesis.感染的危险因素——证据基础概述及数据综合的挑战。
J Glob Health. 2017 Jun;7(1):010417. doi: 10.7189/jogh.07.010417.
4
Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.实施抗生素管理计划:美国传染病学会和美国医疗保健流行病学学会指南
Clin Infect Dis. 2016 May 15;62(10):e51-77. doi: 10.1093/cid/ciw118. Epub 2016 Apr 13.
5
Community-associated Clostridium difficile infection and antibiotics: a meta-analysis.社区相关性艰难梭菌感染和抗生素:一项荟萃分析。
J Antimicrob Chemother. 2013 Sep;68(9):1951-61. doi: 10.1093/jac/dkt129. Epub 2013 Apr 25.
6
Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection.抗生素与社区相关性艰难梭菌感染风险的荟萃分析。
Antimicrob Agents Chemother. 2013 May;57(5):2326-32. doi: 10.1128/AAC.02176-12. Epub 2013 Mar 11.
7
Costs of healthcare- and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms.抗微生物药物耐药与敏感菌所致的医疗保健和社区相关性感染的成本。
Clin Infect Dis. 2012 Sep;55(6):807-15. doi: 10.1093/cid/cis552. Epub 2012 Jun 14.
8
Host and pathogen factors for Clostridium difficile infection and colonization.艰难梭菌感染和定植的宿主和病原体因素。
N Engl J Med. 2011 Nov 3;365(18):1693-703. doi: 10.1056/NEJMoa1012413.
9
Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection.随着时间的推移累积的抗生素暴露与艰难梭菌感染的风险。
Clin Infect Dis. 2011 Jul 1;53(1):42-8. doi: 10.1093/cid/cir301.
10
Rational dosing of antimicrobial agents: pharmacokinetic and pharmacodynamic strategies.抗菌药物的合理给药:药代动力学和药效学策略
Am J Health Syst Pharm. 2009 Jun 15;66(12 Suppl 4):S23-30. doi: 10.2146/090087d.